We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Cocoa Flavonols Increase Blood Flow to Brain

By Biotechdaily staff writers
Posted on 11 Aug 2005
Molecules called flavonols found in cocoa and dark chocolate have demonstrated to be not only healthy for the heart but may also influence blood flow to the brain, according to a new study.

This study may have implications for the ability to treat strokes, diabetes, and vascular dementia, and the data could soon be available to pharmaceutical companies for development into new medications, according to researchers. More...


Prof. Ian MacDonald, professor of physiology at the University of Nottingham (UK), reported that he and coworkers have discovered that cocoa flavonols could increase blood flow to major areas of the brain. In a study of 16 healthy young women, the scientists studied the brain's activation during cognitive tasks using functional magnetic resonance imaging (fMRI).

"The mounting scientific evidence on cocoa flavonols is extraordinary,” said Dr. Norm Hollenberg, professor of Medicine at Harvard Medical School (Boston, MA, USA), and one of the first scientists to discover the potential health benefits of cocoa flavonols. "This is a scientific breakthrough that could well lead to a medical breakthrough.”

Furthermore, researchers at Mars, Inc. (Mount Olive, NJ, USA), a leading candy manufacturer, have found that entire "libraries” of cocoa flavanols can be manufactured, and that new flavanols can be developed from natural flavonols, enhancing their viability for use in pharmaceutical medications. The research was discussed among international researchers at a meeting sponsored by Mars, which has conducted cocoa studies for more than 15 years. The meeting was held in July 2005 in Lucerne (Switzerland).

Prof. MacDonald reported that further studies should evaluate whether flavonols could help individuals who are tired or for people with mild cognitive problems. This increase in blood flow could result from a vascular effect, according to Prof. MacDonald.
In the Nottingham study, the participants consumed the flavonol-rich CocoaVia drink, produced by Mars, once a day for five days before the start of the study. The drink contains 150 mg of flavonols. Earlier studies demonstrated that cocoa flavonols appear to increase nitric oxide synthesis by the blood vessels, thereby increasing blood flow.

At the meeting, investigators at the University Hospital (Zurich, Switzerland) and Harvard Medical School also reported that similar increases in blood flow can be achieved among individuals with diabetes. This suggests that cocoa flavonols could help in treating acute vascular complications associated with long-term diabetes.





Related Links:
University of Nottingham

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Rapid Flu Test
Influenza A&B Rapid Test Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.